By CAMPEP category
View another way?
- Radiotherapy-Nuclear Medicine
2022 AM
Clinical Relevance of Microsphere Characteristics for Radioembolization Treatment
Presented by Marnix Lam Utrecht Medical Center
2022 AM
Current State of Dosimetry With 90Y Microspheres
Presented by Shirin Abbasinejad Enger Medical Physics Unit, McGill University, Montreal, QC, Canada
2022 AM
Dosimetry of Intrathecally Administered 131I-Labeled Omburtamab
Presented by John Laurence Humm, PhD Memorial Sloan-Kettering Cancer Center
2022 AM
Intra-Arterial Administration of Receptor Targeted Agent, 90Y-DOTATOC
Presented by Stephen Graves University of Iowa
2022 AM
Intra-Tumoral Infusion of P-32 Radiolabeled Microspheres for Localized Radiotherapy of Pancreatic Tumors
Presented by William Erwin, MS UT MD Anderson Cancer Center
2022 AM
Therapy of Glioblastoma Using Locoregional Administration of 186Re-Liposomal Nanoparticles
Presented by Ande Bao, PhD University Hospitals Cleveland Medical Center
2022 AM
Y-90 Transarterial Radioembolization for the Treatment of Brain Tumors in a Canine Model
Presented by Sasicha Manupipatpong Johns Hopkins University
2021 SCM
Bio-effect Modeling and Combination Therapy with Radiopharmaceutical Therapies
Presented by Robert Hobbs, Johns Hopkins University
2021 SCM
Dosimetry Methodologies and Nomenclature for Radiopharmaceutical Therapy - MIRD and ICRU
Presented by Wesley Bolch, University of Florida
2021 SCM
Q&A
Presented by Matthew Hough, AdventHealth Orlando
2021 SCM
Quantitative Imaging and Associated Uncertainties in Patient Specific Dosimetry with Radiopharmaceutical Therapies
Presented by Yuni Dewaraja, University of Michigan
